Economic Evaluation of Cancer Drugs
portes grátis
Economic Evaluation of Cancer Drugs
Using Clinical Trial and Real-World Data
Bashir, Zahid; Khan, Iftekhar; Crott, Ralph
Taylor & Francis Ltd
03/2021
416
Mole
Inglês
9780367727079
15 a 20 dias
821
Descrição não disponível.
Índice não disponível.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Progressive Disease;HRQoL Benefit;Economic evaluation;HRQoL Effect;Real world evidence;Minimal Residual Disease;Cancer cost-effectiveness;Baseline HRQoL;Re-imbursement;Partitioned Survival Model;Non-interventional studies;ECOG Status;economic evaluation models;HRQoL Data;oncology drug development;Generic HRQoL Measure;healthcare systems;NHS Reference Cost;cancer drugs;HRQoL Measure;HTA Submission;ITT Population;Cost Effectiveness Threshold;Patient Level Costs;Health Economic Models;Interim Analyses;HRQoL Assessment;Immune Related Response Criteria;RWD Study;HRQoL Issue;Reimbursement Bodies;Health Economic Evaluation;HRQoL Parameter;Patient Level Data
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Progressive Disease;HRQoL Benefit;Economic evaluation;HRQoL Effect;Real world evidence;Minimal Residual Disease;Cancer cost-effectiveness;Baseline HRQoL;Re-imbursement;Partitioned Survival Model;Non-interventional studies;ECOG Status;economic evaluation models;HRQoL Data;oncology drug development;Generic HRQoL Measure;healthcare systems;NHS Reference Cost;cancer drugs;HRQoL Measure;HTA Submission;ITT Population;Cost Effectiveness Threshold;Patient Level Costs;Health Economic Models;Interim Analyses;HRQoL Assessment;Immune Related Response Criteria;RWD Study;HRQoL Issue;Reimbursement Bodies;Health Economic Evaluation;HRQoL Parameter;Patient Level Data
